CVS Health (CVS) shares lost ground in early trading Wednesday after the pharmacy giant slashed its 2024 earnings guidance again amid increased medical costs and announced the departure of the head of its Aetna unit.

The company lowered its 2024 guidance for 澳洲幸运5开奖号码历史查询:earnings per share (EPS) for a🐠 third straight quarter, to a range of $4.95 to $5.20 from at least $🎶5.64 previously.

CVS reported second-quarter revenue of $91.23 billion, up 2.6% from a year ago, but 澳洲幸运5开奖号码历史查询:below forecasts, while EPS of $1.41 beat projections.

🧸 Medicare Claims, Drop in Star Ratings Hit Results

CVS struggled with a rise in Medicare claims during the quarter, and a drop in its 澳洲幸运5开奖号码历史查询:star ratings for those plans. 澳洲幸运5开奖号码历史查询:Medicare and Medicaid are both government-run programs that help cover ﷽health care costs, with Medicare open to Americans 65 and older or who meet certain c🌼riteria.

Aetna President Leaves

The company also said that "based on the current performance and outlook for the Health Care Benefits segment," Aetna President Brian Kane is leaving, and CVS CEO Karen Lynch will take over management of the business and oversee it with CFO Tom Cowhey. 

CVS shares were down 2% at $57.06 in early trading Wednesday following the news and have lost over 2🧜7% of their value so far this🌼 year.